Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
1. Evaluate the efficacy and safety of taking thalidomide tablets once daily in the
treatment of active ankylosing spondylitis.
2. To explore dose-effect relationships of taking thalidomide tablets once daily in the
treatment of active ankylosing spondylitis, as well as selecting the appropriate dose
for the further larger scale clinical trials.